HealthPharm - Page 2
- 16/Jan/2026
- by William Womack
-
multiple myeloma
bone disease
novel agents
myeloma bone lesions
denosumab
Multiple Myeloma: Understanding Bone Disease and the Rise of Novel Treatments
Multiple myeloma causes severe bone damage in over 80% of patients. Learn how bone disease develops, why current treatments fall short, and how novel agents like romosozumab and DKN-01 are finally offering hope for healing-not just slowing-bone destruction.
Read
- 15/Jan/2026
- by William Womack
-
clarithromycin
calcium channel blockers
drug interaction
hypotension
CYP3A4
Clarithromycin and Calcium Channel Blockers: How This Drug Combination Can Cause Dangerous Low Blood Pressure
Clarithromycin can dangerously raise levels of calcium channel blockers like nifedipine and amlodipine, causing life-threatening drops in blood pressure. Azithromycin is the safer alternative.
Read
- 14/Jan/2026
- by William Womack
-
chronic hepatitis C
DAA treatment
hepatitis C cure
liver protection
sofosbuvir velpatasvir
Chronic Hepatitis C: How Modern Antivirals Cure the Virus and Protect the Liver
Chronic hepatitis C can now be cured in 8-12 weeks with oral antivirals that have over 95% success rates. Learn how modern DAAs eliminate the virus, reverse liver damage, and restore health-with minimal side effects and no injections.
Read
- 12/Jan/2026
- by William Womack
-
generic medications
nocebo effect
patient perception
brand vs generic
medication expectations
How to Manage Patient Perception and Nocebo Effects with Generic Medications
Learn how negative beliefs about generic medications can cause real side effects-even when the drugs are identical to brand-name versions. Discover practical ways to manage patient perception and reduce the nocebo effect.
Read
- 11/Jan/2026
- by William Womack
-
NSAID overdose
GI bleeding
NSAID risks
stomach bleeding from painkillers
NSAID safety
NSAID Overdose: How Gastrointestinal Bleeding Happens and What to Do
NSAID overdose can cause silent, life-threatening gastrointestinal bleeding - even from daily use. Learn who’s at risk, how to spot hidden signs, and what to do before it’s too late.
Read
- 10/Jan/2026
- by William Womack
-
specialty drugs
brand-name prescribing
specialty pharmacy
drug pricing
prescriber preferences
Specialty Prescribing: Why Specialists Often Choose Brand-Name Drugs Over Generics
Specialty drugs cost tens of thousands annually but make up less than 7% of prescriptions. Specialists often prefer brand-name versions due to limited alternatives, complex patient needs, and insurance barriers-not profit motives.
Read
- 9/Jan/2026
- by William Womack
-
GLP-1 side effects
meal planning for GLP-1
dose titration tips
Ozempic nausea
Wegovy GI issues
GLP-1 GI Side Effects: Meal Planning and Dose Titration Tips
Manage GLP-1 GI side effects like nausea and vomiting with smart meal planning and slow dose titration. Learn what to eat, when to eat it, and how to adjust your dose to stick with your medication long-term.
Read
- 8/Jan/2026
- by William Womack
-
DPP-4 inhibitors
joint pain
diabetes medication
sitagliptin
side effects
DPP-4 Inhibitors and Joint Pain: What You Need to Know About This Side Effect
DPP-4 inhibitors help control blood sugar in type 2 diabetes, but they can cause severe joint pain - a side effect many patients and doctors miss. Learn the signs, what to do, and how to stay safe.
Read
- 7/Jan/2026
- by William Womack
-
specialty pharmacy
generic specialty drugs
providers
dispensing
biosimilars
Specialty Pharmacy: How Providers Manage Generic Specialty Drugs
Specialty pharmacies handle generic specialty drugs with the same clinical rigor as branded versions. Learn how providers ensure safety, adherence, and continuity of care-even when the drug is cheaper.
Read
- 6/Jan/2026
- by William Womack
-
ICH guidelines
medication safety
pharmaceutical harmonization
ICH S1
ICH E6
ICH M13A
International ICH Guidelines: How Global Harmonization Improves Medication Safety
ICH guidelines harmonize global pharmaceutical standards to ensure safer, faster, and more efficient drug development. Learn how ICH S1, E6, and M13A shape medication safety worldwide.
Read
- 5/Jan/2026
- by William Womack
-
nitrofurantoin
G6PD deficiency
hemolytic anemia
UTI antibiotics
drug safety
Nitrofurantoin and Hemolytic Anemia: What You Need to Know About G6PD Deficiency Risk
Nitrofurantoin is a common UTI antibiotic, but it can cause life-threatening hemolytic anemia in people with G6PD deficiency. Learn who’s at risk, what symptoms to watch for, and safer alternatives.
Read
- 4/Jan/2026
- by William Womack
-
FDA Sentinel Initiative
drug safety
big data
real-world evidence
post-market surveillance
FDA Sentinel Initiative: How Big Data Detects Drug Safety Issues
The FDA Sentinel Initiative uses big data from millions of patient records to detect hidden drug safety issues in real time - replacing outdated reporting systems with active, science-driven monitoring.
Read
